Allegro Ophthalmics announced that William J. Link, PhD, has been elected to Allegro’s board of directors. Dr. Link is cofounder and a managing director of Versant Ventures, a global healthcare investment firm where he specializes in early stage investing in medical devices. Prior to Versant, Dr. Link was a general partner at Brentwood Venture Capital. With more than 2 decades of operations experience in the health care industry, Dr. Link has a proven record of building and managing large, successful medical product companies, including Chiron Vision where he was cofounder, chairman, and CEO until it was sold to Bausch + Lomb in 1997. In addition, Dr. Link founded and served as President of American Medical Optics (AMO), a division of American Hospital Supply Corporation, which was sold to Allergan in 1986.
“Bill is a pioneer in the health care industry and we are excited to welcome him to Allegro’s board of directors,” Hampar Karageozian, MSc, MBA, cofounder and chief executive officer, Allegro Ophthalmics, said in a company news release. “Bill’s vast experience and expertise in building and managing successful health care companies, particularly in the area of ophthalmology, will be a tremendous asset that will ensure Allegro’s continued success as we move our lead drug candidate Luminate toward commercialization.”
“I have admired how Allegro’s dynamic leadership team has quickly and cost-effectively made significant progress in its Luminate drug development program across multiple indications,” said Dr. Link. “With this recent progress, including last month’s news on the positive results from the DEL MAR Phase 2b DME trial, it is a very exciting time to join Allegro’s board of directors.”